Nova Scotia Health Research Foundation   Report issue

Academic/Hospital Phase 3 Phase 4
Founded: Nova Scotia Canada (2000)
Status: Defunct (2019)

Organization Overview

First Clinical Trial
2002
NCT00819325
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Nova Scotia Health Research Foundation | Research Nova Scotia

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acute Pain (Phase 3)

Angina Pectoris (Phase 4)

Atrial Fibrillation (Phase 4)

Coronary Artery Disease (Phase 4)

Dyspnea (Phase 3)

Lung Diseases (Phase 3)

Lung Diseases, Obstructive (Phase 3)

Neuralgia (Phase 4)

Pulmonary Disease, Chronic Obstructive (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 6
  • # of Trial APIs: 11